V
Vifor Pharma AG
SIX:VIFN
Vifor Pharma AG
SIX:VIFN
Price:
166.15 CHF
0.48%
Market Closed
Updated:
May 17, 2024
Vifor Pharma AG
Total Other Income
|
Vifor Pharma AG
Total Other Income Peer Comparison
Comparables:
NOVN
NLSP
ROG
S
SDZ
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
V
|
Vifor Pharma AG
SIX:VIFN
|
Total Other Income
-CHf1m
|
CAGR 3-Years
46%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
Novartis AG
SIX:NOVN
|
Total Other Income
$318m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Roche Holding AG
SIX:ROG
|
Total Other Income
-CHf189m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-37%
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Total Other Income
-$34m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vifor Pharma AG's Total Other Income?
Total Other Income
-1m
CHF
-1m
CHF
Based on the financial report for Dec 31, 2021, Vifor Pharma AG's Total Other Income amounts to -1m CHF.
What is Vifor Pharma AG's Total Other Income growth rate?
Total Other Income CAGR 5Y
27%
27%
Over the last year, the Total Other Income growth was -11%. The average annual Total Other Income growth rates for Vifor Pharma AG have been 46% over the past three years , 27% over the past five years .
You don't have any saved screeners yet
